13.07.2015 Views

Volume. 35, No. 2 july. 2011 - The Chest and Heart Association of ...

Volume. 35, No. 2 july. 2011 - The Chest and Heart Association of ...

Volume. 35, No. 2 july. 2011 - The Chest and Heart Association of ...

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

<strong>Chest</strong> & <strong>Heart</strong> Journal Vol. <strong>35</strong>, <strong>No</strong>.-2, July <strong>2011</strong>FDA Pregnancy Risk CategoryCategoryABCDXInterpretationControlled studies show no risk, Adequate, well-controlled studies in pregnant womenhave failed to demonstrate a risk to the fetus in any trimester <strong>of</strong> pregnancy<strong>No</strong> evidence <strong>of</strong> risk in humans. Adequate well-controlled studies in pregnant womenhave not shown increased risk <strong>of</strong> fetal abnormalities despite adverse findings in animals,orin the absence <strong>of</strong> adequate human studies ,animal studies show no fetal risk .<strong>The</strong> chance<strong>of</strong> fetal harm is remote,but remains a possibilities .Risk cannot be ruled out.Adequate well-controlled human studies are lacking <strong>and</strong> animalstudies have shown a risk to the fetus or are lacking as well there is a chance <strong>of</strong> fetalharm if the drug is administered during pregnancy but the potential benefits mayoutweigh the potential riskPositive evidence <strong>of</strong> risk .Studies in humans, or investigational or post marketing data,have demonstrated fetal risk.Nevertheless, potential benefits from the use <strong>of</strong> the drugmay outweigh the potential risk.Contraindicated in pregnancy . Studies in animals or humans or investigational or postmarketing reports have demonstrated positive evidence <strong>of</strong> fetal abnormalities or riskthat clearly outweighs any possible benefits to the patients .FDA Pregnancy risk category, TERIS rating <strong>of</strong> asthma medication 5Medication Risk Category TERIS rating(magnitude <strong>of</strong> teratogenic Risk/Quality,Quantity <strong>of</strong> Data)Salbutamol C Undetermined/LimitedLevo-salbutamol C NASameterol C Undetermined/Very LimitedBeclomethasone C Unlikely/Limited to FairBudesonide B Unlikely/Limited to FairFluticasone C NAMometasone C Undetermined/LimitedTriamcinolone C Undetermined/LimitedFluticasone/salmeterol C NAOral steroidCCromolyn B Unlikely/Fair to GoodNedocromil B Undetermined/Very LimitedMontelukast D Undetermined/Limit<strong>The</strong>ophylline C <strong>No</strong>ne/Fair to GoodSteps <strong>of</strong> Asthma <strong>The</strong>rapy during PregnancyStep Preferred Controller Medication Alternative Controller Medication1 <strong>No</strong>ne2 LDICS LTRA,theophylline,or cromolyn3 MDICS LDICS plus LABA,LTRAor theophylline4 MDICS plus LABA MDICS plus either LTRA or theophylline5 HDICS plus LABA6 HDICS plus LABA plus oral prednisolone110

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!